These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6438923)

  • 21. Exogenous uridine diphosphoglucuronic acid breakdown in rat small intestinal mucosa preparations. Effect of other nucleotides.
    Mottino AD; Denoya O; Rodríguez Garay EA
    Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):455-8. PubMed ID: 4059659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of model traumatic injury on hepatic drug metabolism in the rat. IV. Glucuronidation.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1985; 13(4):391-7. PubMed ID: 2863100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant.
    Miller MG; Beyer J; Hall GL; deGraffenried LA; Adams PE
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):108-16. PubMed ID: 8378925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered acetaminophen disposition in fed and food-deprived rats after acute ethanol administration.
    Minnigh MB; Zemaitis MA
    Drug Metab Dispos; 1982; 10(2):183-8. PubMed ID: 6124407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of glucuronidation of benzo(a)pyrene phenols by long-chain fatty acids.
    Zhong Z; Kauffman FC; Thurman RG
    Cancer Res; 1991 Sep; 51(17):4511-5. PubMed ID: 1908348
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of benzo(a)pyrene metabolism with microsomes by addition of uridine 5'-diphosphoglucuronic acid.
    Nemoto N; Takayama S
    Cancer Res; 1977 Nov; 37(11):4125-9. PubMed ID: 908046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of cadmium-decreased glucuronidation in the rat.
    Alary J; Cravedi JP; Baradat M; Carrera G
    Biochem Pharmacol; 1992 Dec; 44(11):2139-47. PubMed ID: 1472079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficiency in bilirubin UDP-glucuronyl transferase as a genetic determinant of acetaminophen toxicity.
    de Morais SM; Wells PG
    J Pharmacol Exp Ther; 1988 Oct; 247(1):323-31. PubMed ID: 3139868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity.
    Price VF; Jollow DJ
    J Pharmacol Exp Ther; 1982 Mar; 220(3):504-13. PubMed ID: 7062262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of glucuronidation by glutathione redox state through the alteration of UDP-glucose supply originating from glycogen metabolism.
    Braun L; Kardon T; Puskás F; Csala M; Bánhegyi G; Mandl J
    Arch Biochem Biophys; 1997 Dec; 348(1):169-73. PubMed ID: 9390188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dependence of glucuronidation rate on UDP-glucuronic acid levels in isolated hepatocytes.
    Singh J; Schwarz LR
    Biochem Pharmacol; 1981 Dec; 30(23):3252-4. PubMed ID: 7317109
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of butylated hydroxyanisole on acetaminophen hepatotoxicity and glucuronidation in vivo.
    Hazelton GA; Hjelle JJ; Klaassen CD
    Toxicol Appl Pharmacol; 1986 May; 83(3):474-85. PubMed ID: 3085287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and functional characterization of microsomal UDP-glucuronic acid uptake by members of the nucleotide sugar transporter (NST) family.
    Kobayashi T; Sleeman JE; Coughtrie MW; Burchell B
    Biochem J; 2006 Dec; 400(2):281-9. PubMed ID: 16965264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition by ranitidine of acetaminophen conjugation and its possible role in ranitidine potentiation of acetaminophen-induced hepatotoxicity.
    Rogers SA; Gale KC; Newton JF; Dent JG; Leonard TB
    J Pharmacol Exp Ther; 1988 Jun; 245(3):887-94. PubMed ID: 3133464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat.
    Price VF; Miller MG; Jollow DJ
    Biochem Pharmacol; 1987 Feb; 36(4):427-33. PubMed ID: 3827934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyrophosphatase and glucuronosyltransferase in microsomal UDPglucuronic-acid metabolism in the rat liver.
    Puhakainen E; Hänninen O
    Eur J Biochem; 1976 Jan; 61(1):165-9. PubMed ID: 1276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of fasting on metabolite-mediated hepatotoxicity in the rat.
    Pessayre D; Dolder A; Artigou JY; Wandscheer JC; Descatoire V; Degott C; Benhamou JP
    Gastroenterology; 1979 Aug; 77(2):264-71. PubMed ID: 109346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of genetic obesity and phenobarbital treatment on the hepatic conjugation pathways.
    Chaudhary IP; Tuntaterdtum S; McNamara PJ; Robertson LW; Blouin RA
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1333-8. PubMed ID: 8510012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
    Watkins JB; Klaassen CD
    J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of covalent adduct formation of diclofenac to rat hepatic microsomal proteins. Retention of the glucuronic acid moiety in the adduct.
    Kretz-Rommel A; Boelsterli UA
    Drug Metab Dispos; 1994; 22(6):956-61. PubMed ID: 7895615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.